Sign up to save your podcasts
Or
Share Kisunla: New FDA-Approved Alzheimer's Drug Explained
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Kisunla: New FDA-Approved Alzheimer's Drug Explained
On this special episode we’re discussing the new FDA-approved drug Kisunla (donanemab) for the treatment of people living with early symptomatic Alzheimer’s disease. We’re joined by Dr. Margarita Reyes, a physician at Bristol Health Group in Connecticut, who explains how Kisunla works, the difference between Kisunla and Leqembi, side effects, and much more.
Need assistance? Call the Alzheimer’s Association 24/7 Helpline (800.272.3900).
View all episodes
By Alzheimer's Association New England Region
5
77 ratings
On this special episode we’re discussing the new FDA-approved drug Kisunla (donanemab) for the treatment of people living with early symptomatic Alzheimer’s disease. We’re joined by Dr. Margarita Reyes, a physician at Bristol Health Group in Connecticut, who explains how Kisunla works, the difference between Kisunla and Leqembi, side effects, and much more.
Need assistance? Call the Alzheimer’s Association 24/7 Helpline (800.272.3900).
More shows like Speaking of Alzheimer's
View all
Fresh Air
37,872 Listeners
The Moth
27,080 Listeners
Planet Money
30,672 Listeners
TED Radio Hour
21,892 Listeners
Hidden Brain
43,359 Listeners
Nutrition Facts with Dr. Greger
3,443 Listeners
The Proof with Simon Hill
2,601 Listeners
The Dr. Hyman Show
9,279 Listeners
Chasing Life
8,224 Listeners
SmartLess
57,384 Listeners
Good Inside with Dr. Becky
4,454 Listeners
A Slight Change of Plans
2,053 Listeners
All There Is with Anderson Cooper
9,546 Listeners
Truth, Lies & Alzheimer's
17 Listeners
Letters from an American
5,318 Listeners